Protein kinase A inhibits intermediate conductance Ca2+-activated K+ channels expressed in Xenopus oocytes

被引:0
|
作者
Craig B. Neylon
Theresa D’Souza
Peter H. Reinhart
机构
[1] Duke University Medical Center,Department of Neurobiology
[2] University of Melbourne,Department of Anatomy and Cell Biology
来源
Pflügers Archiv | 2004年 / 448卷
关键词
Calcium-activated; cAMP; IK channel; Intermediate conductance; Potassium channel; Protein kinase A;
D O I
暂无
中图分类号
学科分类号
摘要
Intermediate-conductance (IK) Ca2+-activated K+ channels are expressed in many different cell types where they perform a variety of functions including cell volume regulation, transepithelial secretion, lymphocyte activation and cell cycle progression. IK channels are thought to be regulated by phosphorylation; however, whether kinases act directly on the channel is unclear. Using IK channels heterologously expressed in Xenopus oocytes, we demonstrate that IK channels are potently inhibited (60%) by the catalytic subunit of protein kinase A (PKA). Inhibition of IK channel current by PKA is abolished by mutation of four phosphorylation residues (S312, T327, S332, and T348) in the putative calmodulin-binding region of the channel. Evidence for direct modulation of the IK channel by PKA was further demonstrated using GST fusion proteins. The major site of phosphorylation was found to be serine 332; however, other residues were also phosphorylated. We conclude that IK channels can be directly regulated by the cAMP second-messenger system. The mechanism appears to involve direct phosphorylation by PKA of a modulatory locus in the cytoplasmic region of the channel, the site at which calmodulin is thought to interact. Modulation of IK channels by protein kinases may be an important mechanism regulating cell function.
引用
收藏
页码:613 / 620
页数:7
相关论文
共 50 条
  • [1] Protein kinase A inhibits intermediate conductance Ca2+-activated K+ channels expressed in Xenopus oocytes
    Neylon, CB
    D'Souza, T
    Reinhart, PH
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 448 (06): : 613 - 620
  • [2] Xenopus laevis oocytes contain endogenous large conductance Ca2+-activated K+ channels
    Krause, JD
    Foster, CD
    Reinhart, PH
    NEUROPHARMACOLOGY, 1996, 35 (07) : 1017 - 1022
  • [3] Benzamil inhibits neuronal and heterologously expressed small conductance Ca2+-activated K+ channels
    Castaneda, Marisol Sampedro
    Tonini, Raffaella
    Richards, Christopher D.
    Stocker, Martin
    Pedarzani, Paola
    NEUROPHARMACOLOGY, 2019, 158
  • [4] Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels
    Nam, Young-Woo
    Downey, Myles
    Rahman, Mohammad Asikur
    Cui, Meng
    Zhang, Miao
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (02) : 259 - 267
  • [5] Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels
    Young-Woo Nam
    Myles Downey
    Mohammad Asikur Rahman
    Meng Cui
    Miao Zhang
    Acta Pharmacologica Sinica, 2023, 44 : 259 - 267
  • [6] Small conductance Ca2+-activated K+ channels and calmodulin
    Maylie, J
    Bond, CT
    Herson, PS
    Lee, WS
    Adelman, JP
    JOURNAL OF PHYSIOLOGY-LONDON, 2004, 554 (02): : 255 - 261
  • [7] Expression of sperm Ca2+-activated K+ channels in Xenopus oocytes and their modulation by extracellular ATP
    Chan, HC
    Wu, WL
    Sun, YP
    Leung, PS
    Wong, TP
    Chung, YW
    So, SC
    Zhou, TS
    Yan, YC
    FEBS LETTERS, 1998, 438 (03) : 177 - 182
  • [8] Intermediate Conductance Ca2+-Activated K+ Channels Modulate Human Placental Trophoblast Syncytialization
    Diaz, Paula
    Wood, Amber M.
    Sibley, Colin P.
    Greenwood, Susan L.
    PLOS ONE, 2014, 9 (03):
  • [9] NPPB block of the intermediate conductance Ca2+-activated K+ channel
    Fioretti, B
    Castigli, E
    Calzuola, I
    Harper, AA
    Franciolini, F
    Catacuzzeno, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 497 (01) : 1 - 6
  • [10] Role of augmented expression of intermediate-conductance Ca2+-activated K+ channels in postischaemic heart
    Saito, T
    Fujiwara, Y
    Fujiwara, R
    Hasegawa, H
    Kibira, S
    Miura, H
    Miura, M
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2002, 29 (04) : 324 - 329